Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -2.62EBIT per Share
VS
Market
Sector
Industry
History
$ 8.77Close
$ 1.79 - $ 11.12 52-Week Range
Ticker Information
Ticker
LXEOCompany Name
LEXEO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQLEXEO THERAPEUTICS INC - EBIT per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LXEO - EBITPS Historical data
| Date | Earning Before Interest & Taxes (EBIT) | EBIT per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -114.05M | $ -2.62 | 1 | 43.57M |
| 3/31/2025 | $ -109.18M | $ -3.3 | 1 | 33.11M |
| 12/31/2024 | $ -98.2M | $ -3.09 | 1 | 31.79M |
| 9/30/2024 | $ -86.44M | $ -2.61 | 1 | 33.06M |
| 6/30/2024 | $ -77.04M | $ -2.33 | 1 | 33M |
| 3/31/2024 | $ -69.23M | $ -2.47 | 1 | 27.98M |
| 12/31/2023 | $ -66.19M | $ -12.36 | 1 | 5.35M |
| 9/30/2023 | $ 0 | $ 0 | 1 | 1.63M |
| 6/30/2023 | $ 0 | $ 0 | 1 | 1.62M |
| 12/31/2022 | $ -59.19M | $ -36.3 | 1 | 1.63M |
Key Performance Insights, Last 5 Years
- LEXEO THERAPEUTICS INC's latest trailing twelve months (TTM) EBITPS stands at $ -36.3.
- Over the past 5 years, LEXEO THERAPEUTICS INC's average EBITPS has been $ -8.14.
- The median EBITPS for LEXEO THERAPEUTICS INC during this period was $ -2.85
- LEXEO THERAPEUTICS INC reached its highest EBITPS over the past 5 years at $ -2.33.
- The lowest EBITPS recorded by LEXEO THERAPEUTICS INC in the same timeframe $ -36.3
Similar metrics to Shares WA:
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBIT per Share
[Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBIT / (Shares WA * Share Factor)
(=) EBITPS EBITPS for LEXEO THERAPEUTICS INC is calculated as follows: EBIT [ $ -59.19M ] / (Shares WA [ 1.63M ] * Share Factor [ 1 ])
(=) EBITPS [ $ -36.3 ] LXEO - EBIT per Share, Last 5 years
$ -36.3
Minimum
Dec 31, 2022
$ -2.33
Maximum
Jun 30, 2024
$ -8.14
Average
$ -2.85
Median
EBITPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITPS for companies in the Total Stock Market. The average EBITPS of the companies is $ 1.16 with a standard deviation of $ 3.42.
The following table provides additional summary stats:
EBITPS in the Market:
| filtered constituents | 3.79K |
|---|---|
| min | $ -9.72 |
| max | $ 10.76 |
| average | $ 1.16 |
| median | $ 0.38 |
| std | $ 3.42 |